Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02873130 · ClinicalTrials.gov registry record · NA
Effectiveness of Telepractice by Smartphone App Technology in Preventing Voice Problems
A NA study, sponsored by West Chester University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT02873130: Completed NA study, sponsored by West Chester University of Pennsylvania.
NCT02873130 is a NA study that has completed, run by West Chester University of Pennsylvania. The registered enrollment target is 103 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02873130, a NA study, has completed, sponsored by West Chester University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
Voice disorders in teachers have a significant impact on communication, quality of life, and economic costs to the healthcare system. We need to advance the prevention of voice disorders in teachers by testing an online telepractice model with synchronous (in real-time) and asynchronous (stored and accessed later) methods. The current study will investigate the effectiveness of the theoretically-driven Global Voice Prevention Model (GVPM) delivered by two methods; 1) online telepractice (synchronous and asynchronous) and 2) traditional, in-person for vocally healthy physical education and vocal music student teachers. Effectiveness of the model will be assessed by voice-related measures captured daily on a smartphone app during student teaching, matching the asynchronous aspects of the telepractice model and representing the effects of vocal loading from teaching.
Primary Outcome
Question will be asked twice a day before and after teaching.
Interventions
- BEHAVIORAL Telepractice Global Voice Prevention Model
- BEHAVIORAL In-person Global Voice Prevention Model
- BEHAVIORAL Telepractice, Vocal Hygiene and Vocal Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2016-08 |
| Est. Completion | 2020-06-01 |
| Phase | NA |
What the finished NCT02873130 record still lists
NCT02873130 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which Telepractice Global Voice Prevention Model is the first listed.
NCT02873130 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02873130 about?
NCT02873130 is a clinical study titled "Effectiveness of Telepractice by Smartphone App Technology in Preventing Voice Problems". Voice disorders in teachers have a significant impact on communication, quality of life, and economic costs to the healthcare system. We need to advance the prevention of voice disorders in teachers by testing an online telepractice model with synchronous (in real-time) and asynchronous (stored and ...
What is the current status of trial NCT02873130?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2016-08. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT02873130?
The interventions under investigation include: Telepractice Global Voice Prevention Model (BEHAVIORAL), In-person Global Voice Prevention Model (BEHAVIORAL), Telepractice, Vocal Hygiene and Vocal Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT02873130?
This trial is sponsored by West Chester University of Pennsylvania, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02873130's enrollment target sits among peer trials
103 837th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia